{"id":4467,"date":"2021-07-13T14:09:00","date_gmt":"2021-07-13T12:09:00","guid":{"rendered":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/?p=4467"},"modified":"2021-10-07T17:24:45","modified_gmt":"2021-10-07T15:24:45","slug":"wtumvs","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wtumvs\/","title":{"rendered":"Regulaci\u00f3n teletrabajo"},"content":{"rendered":"\n<p class=\"has-text-align-justify\">La secci\u00f3n sindical CCOO, con el apoyo de las secciones sindicales UGT, USOC y el Comit\u00e9 de Pensa, ha presentado una propuesta de acuerdo a la empresa para aplicar la regulaci\u00f3n del Teletrabajo en Towa.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Esta propuesta de acuerdo persigue tres objetivos:<\/p>\n\n\n\n<p class=\"has-text-align-justify\">1 &#8211; La aplicaci\u00f3n del real decreto 28\/2020 y lo recogido en el reci\u00e9n firmado Convenio de Qu\u00edmicas (algo que la Empresa no est\u00e1 haciendo a d\u00eda de hoy).<\/p>\n\n\n\n<p class=\"has-text-align-justify\">2 &#8211; Concreta aquellas materias que la Ley deja en manos de la negociaci\u00f3n colectiva o de acuerdos alcanzados en las empresas.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">3 &#8211; Mejora la Ley en algunos aspectos clave.<\/p>\n\n\n\n<p class=\"has-text-align-justify\">Quedamos a la espera de respuesta por parte de la empresa, os seguiremos informando.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La secci\u00f3n sindical CCOO, con el apoyo de las secciones sindicales UGT, USOC y el Comit\u00e9 de Pensa, ha presentado una propuesta de acuerdo a la empresa para aplicar la &#8230; <a title=\"Regulaci\u00f3n teletrabajo\" class=\"read-more\" href=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wtumvs\/\" aria-label=\"Leer m\u00e1s sobre Regulaci\u00f3n teletrabajo\">Leer m\u00e1s<\/a><\/p>\n","protected":false},"author":59,"featured_media":694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,25,26,32],"tags":[],"class_list":["post-4467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-notesinformatives","category-notesinformatives_ca","category-prueba","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/4467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=4467"}],"version-history":[{"count":4,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/4467\/revisions"}],"predecessor-version":[{"id":4505,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/4467\/revisions\/4505"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media\/694"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=4467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=4467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=4467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}